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Background: During June-July 2012, six imipenem-resistant Escherichia coli isolates were isolated from two patients
hospitalized in a ward of one large tertiary-care hospital in Genoa, Italy. Genetic features associated with blaNDM-4
gene were investigated.
Results: The isolates exhibited the same PFGE profile and a multidrug-resistant (MDR) phenotype to aminoglycosides,
fluoroquinolones, and β-lactams. The strains produced the NDM-4 carbapenemase and the blaNDM-4 gene was
part of the variable region of a class 1 integron. MLST analysis revealed that all isolates belonged to sequence
type 405 (ST405).
Conclusions: This is the first report on the emergence of an MDR strain of E.coli producing the NDM-4 MBL in Italy.
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The emerging New Delhi metallo-β-lactamase (NDM),
an acquired class B carbapenemase that was first detected
in Klebsiella pneumoniae isolate from a Swedish patient of
Indian origin has become a major public health concern
worldwide [1].
Two cases of the new variant, NDM-4, have been re-
cently described in isolated recovered from patients previ-
ously hospitalized in India and Cameroon [2,3]. In Italy, a
few cases of NDM-1 producing E.coli and K.pneumoniae
have been reported during 2009 and 2011 [4,5].
In this study we described six NDM-4-producing E.coli
isolates obtained from two patients admitted to an Italian
hospital. We also present data on the localization and the
genetic environment of the blaNDM-4 gene.Methods
Bacterial strains
Six E.coli isolated from urine samples of two inpatients
at the San Martino-IST University Hospital (Genoa, Italy)
were studied. Isolates were taken as part of standard patient* Correspondence: anna.marchese@unige.it
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been obtained by both patients.
Strain identification, antibiotic susceptibility testing and
phenotypic screening for MBL production
Routine identification and antibiotic susceptibility testing
were carried out using the Vitek-2 automated system
(BioMérieux, Marcy-L’etoile, France). In vitro activity
of carbapenems, aztreonam, fosfomycin and nitrofurantoin
was further determined by the broth microdilution method
and interpreted according to the of European Committee
on Antimicrobial Susceptibility Testing (EUCAST ) guide-
lines (Version 4.0, 2014) [6]. To detect metallo-β-lactamase
(MBL) production, a synergy test using imipenem and
EDTA discs was used [7].
Pulsed-field gel electrophoresis (PFGE)
Genomic DNA was prepared, digested with XbaI (New
England Biolabs Inc., MA, USA) and subjected to PFGE
with the CHEF DRII device (Bio-rad, Milan, Italy), as
described previously [8]. Fingerprinting pattern was inter-
preted according to the method of Tenover et al. [9].
Multilocus sequence typing (MLST)
MLST was carried out using protocols and conditions
described on the E.coli MLST website (http://mlst.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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html). Sequence types were assigned using the website
interface.
Molecular analysis techniques
Polymerase chain reaction (PCR) amplification of the
blaNDM gene and direct sequencing of the PCR products
was performed as previously described [10]. Screening for
resistance genes was carried out using primers and condi-
tions previously described [11-13]. Phylogenetic analysis
using multiplex PCR method as described previously [14]
was used. PCR experiments were performed to identify the
upstream- and downstream-located regions of the blaNDM-4
gene [15]. Mapping of the variable region of class 1 inte-
gron was performed by PCR as described previously [16].
The genetic environment of blaNDM-4 was studied by PCR
mapping and sequencing as described previously [13].
Conjugation assay and plasmid study
Plasmid transfer was attempted by conjugation, using E.coli
J53 as the recipient, as described previously [17]. Plasmid
DNA, isolated from E.coli, was obtained by the alkaline
lysis method and was used as a template in PCR analysis
with primers that are specific for blaNDM and blaCTX-M
[18]. To rule out chromosomal DNA contamination the
template was used to amplify an internal fragment of the
house-keeping recA gene. A PCR-based replicon typing
method was used to identify the incompatibility group [19].
Results
Bacteria and patients
The first NDM-4-positive E.coli isolate (URO734, index
strain) was detected from the urine of a 61-year-old male
inpatient (patient 1) of the rehabilitation unit of the SanFigure 1 Time of isolation of NDM-4 positive E.coli from patient 1 andMartino-IST Hospital on 30 June 2012 (Figure 1). At the
beginning of June, the patient was hospitalized for 7 days,
in a hospital in New Delhi, India, with a history of right
middle cerebral artery ischemic stroke and left-sided hemi-
paresis. On 15 June 2012 the patient was admitted to San
Martino-IST stroke center and on 26 June he was trans-
ferred in the rehabilitation unit for 57 days. Subsequent
urine samples, collected during the hospitalization period
(9 July, 12 July, 27 July), continued to yield NDM-4-positive
E. coli showing the same MDR phenotype as URO734 until
27 July. The patient was empirically treated with colistin.
Subsequent urine samples (03 August, 09 August) were
negative for E. coli.
A second case of urinary tract infection sustained by
NDM-4-positive E. coli was detected in July 2012 in an-
other inpatient (patient 2), a 79-year-old man, with a
history of hip replacement, who was admitted to the
same rehabilitation unit during a period overlapping the
admittance of the index case. The first isolate from pa-
tient 2 (isolate URO735) was contemporary with the sec-
ond isolate from patient 1. Subsequent urine sample,
collected during the admission period (17 July), contin-
ued to yield NDM-4-positive E. coli, showing the same
MDR phenotype as URO734. Initially, the patient was
empirically treated with pipemidic acid and then, after
antimicrobial susceptibility results were available, with
nitrofurantoin. The clinical condition of the patient im-
proved and the patient was discharged, without further
positive urine culture. No history of travel in India or
other NDM endemic areas was reported for this patient.
Antimicrobial susceptibility
The NDM-4-positive E. coli isolates exhibited a MDR
phenotype to aminoglycosides, fluoroquinolones, and all2.





AK AMC CAZ LEV CO IPM MER GM TYG SXT CTX NIT FOS AZT
URO734 1 30 Jun Urine >64 >32 >64 >8 <0,5 16 >128 >16 <0,5 >320 >64 64 <2 >64
URO734 1 09 Jul Urine >64 >32 >64 >8 <0,5 16 >128 >16 <0,5 >320 >64 64 <2 >64
URO734 1 12 Jul Urine >64 >32 >64 >8 <0,5 16 >128 >16 <0,5 >320 >64 64 <2 >64
URO734 1 27 Jul Urine >64 >32 >64 >8 <0,5 16 >128 >16 <0,5 >320 >64 64 <2 >64
URO735 2 09 Jul Urine >64 >32 >64 >8 <0,5 16 >128 >16 <0,5 >320 >64 64 <2 >64
URO735 2 17 Jul Urine >64 >32 >64 >8 <0,5 16 >128 >16 <0,5 >320 >64 64 <2 >64
AK: amikacin; AMC: amoxicillin/clavulanic acid; CAZ: ceftazidime; LEV: levofloxacin; CO: colistin; IPM: imipenem; MER: meropenem; GM: gentamicin; TYG: tigecycline;
SXT: thrimethoprim/sulfamethoxazole; CTX: cefotaxime; NIT: nitrofurantoin; FOS: fosfomycin, AZT: aztreonam.
Figure 2 PFGE profiles of the blaNDM4 -positive E.coli isolates
following digestion with XbaI.
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nitrofurantoin, fosfomycin and tigecycline (Table 1). All
NDM-4-positive isolates produced metallo-β-lactamase
(MBL) activity by the imipenem-EDTA double-disk syn-
ergy test.
Phylogenetic group and PFGE
E. coli can be classified as phylogroup A, B1, B2 or D ac-
cording to the phylogenetic relationship of the sequences.
Phylogenetic analysis showed that isolates belonged to the
phylogenetic group D, which includes extra-intestinal iso-
late. All isolates exhibited the same PFGE macrorestric-
tion profile (Figure 2).
MLST
All the NDM4-positive isolates were designated to a cer-
tain MLST sequence type by the combination of the seven
allelic housekeeping genes. MLST analysis revealed that all
isolates belonged to sequence type 405 (ST405).
Genetic context of blaNDM4
In the index isolate, PCR and sequencing analysis detected
the presence of blaNDM-4 and of the following acquired re-
sistance genes: blaTEM-1, blaCTX-M-15, dfrA12, aac (3)-II,
aadA2. No other carbapenemase genes (OXA-48 or VIM
types) were identified in these isolate. The resistance de-
terminants dfrA12 and aadA2 were carried on gene cas-
sette inserted into a class 1 integron (Figure 3), resulting
in a cassette array identical to that previously described in
E.coli GUE-NDM isolate from India (accession number
JQ364967).
Genetic structures surrounding the blaNDM-4 gene
performed by PCR identified immediately upstream of the
gene the ISAba125 insertion sequence and downstream of
the gene was identified the bleMBL gene encoding the re-
sistance to bleomycin (Figure 3).
Plasmid features
The blaNDM gene could not be transferred by conjugation
to E.coli J53 recipient. All strains carried a large plasmid(>23 Kb) and when the plasmid band was extracted from
the gel and used as templates for the amplification of the
blaNDM and blaCTX-M genes, the specific products were
detected, suggesting that both resistance determinants
resided in this plasmid. The PCR-based replicon typing
method showed that blaNDM-4 -positive plasmid belonged
to the IncF incompatibility group.
Figure 3 Schematic representation of genetic structures
surrounding blaNDM4 (A) and structure of class 1 integron (B).
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In this communication, we described the first isolation
of NDM-4 producing E.coli in Italy, represented by E.coli
of sequence type 405(ST405). E.coli ST405 belonging to
phylogenetic group D is increasingly reported as multi-
drug resistant strains causing extra-intestinal infections
[20] and is a well-known pandemic clonal lineage im-
plicated as vehicles driving the international spread of
blaCTX-M [21].
NDM is not associated with certain clones, plasmids
or transposons [13], our blaNDM-4 -positive plasmid
belonged to the IncF incompatibility group which is known
to be a major vehicle for dissemination of the blaCTX-M-15
gene [22].
By analyzing genetic structures surrounding the blaNDM-4
gene, we identified insertion sequence ISAba125 upstream
and the bleomycin resistance gene downstream of the
blaNDM-4 gene, this genetic environment of our NDM
isolates was the same observed for most NDM-1 posi-
tive enterobacterial isolates [13].
In both patients, after treatment with in vitro active
antimicrobial agents (colistin and nitrofurantoin), clinical
improvement was observed and in subsequent urine sam-
ples of patient 1 E. coli NDM-4 was no longer isolated. Pa-
tient 2 was discharged without further microbiological
investigation.
Patient 1 was previously hospitalized in India, a geo-
graphical region with high prevalence of NDM-producing
isolates. This is the first example of importation of an In-
dian NDM-4-producing isolate in Italy following a hospital
transfer, confirming the recent observations suggesting that
the Indian subcontinent may represent an important reser-
voir of NDM producers. Because patient 2 had not a his-
tory of travel to NDM endemical areas and PFGE profile of
the strains was identical, it is plausible that a spread of
NDM-4 -producing E.coli from patient 1 to patient 2
occurred.According to the hospital microbiology laboratory re-
cords, no further isolation of NDM-4-positive bacteria
was reported to date in our hospital. To our knowledge,
we report here the first NDM-4 producing E.coli de-
tected in Italy and the fourth worldwide [2,3,23] . NDM-
4 producing E.coli strains have been previously described
in patients from India, Cameroon and Denmark. In this
last case, the Danish patient was previously hospitalizes
in Vietnam. In three cases (Cameroon, Denmark and
Italy), isolates belonged to the ST405 sequence type.
This finding is alarming because, ST405, has been previ-
ously identified as a successful international sequence
type and it could favor the spread of NDM producers.
Conclusions
This is the first report on the emergence of an MDR
strain of E.coli producing the NDM-4 MBL in Italy as
the result of importation of an Indian NDM-4-producing
isolate following a hospital transfer. The isolate belonged
to a well-known international sequence type (ST405) able
to spread and cause outbreak.
Our data confirms the need for a systematic screening
to rapidly detect NDM-producing strains especially among
patients previously hospitalized in the endemic geographic
areas to avoid dissemination of carbapenemase-producing
Enterobacteriaceae.
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